nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP2A6—prostate cancer	0.128	0.35	CbGaD
Flunitrazepam—CYP2E1—prostate cancer	0.0906	0.248	CbGaD
Flunitrazepam—CYP2C19—prostate cancer	0.0897	0.246	CbGaD
Flunitrazepam—CYP3A4—prostate cancer	0.057	0.156	CbGaD
Flunitrazepam—UGT1A1—Estradiol—prostate cancer	0.0284	0.0682	CbGbCtD
Flunitrazepam—UGT2B7—Epirubicin—prostate cancer	0.0275	0.0661	CbGbCtD
Flunitrazepam—CYP2C19—Bicalutamide—prostate cancer	0.0203	0.0487	CbGbCtD
Flunitrazepam—CYP2C19—Nilutamide—prostate cancer	0.0203	0.0487	CbGbCtD
Flunitrazepam—CYP2E1—Estrone—prostate cancer	0.0194	0.0466	CbGbCtD
Flunitrazepam—CYP2B6—Estrone—prostate cancer	0.0191	0.0459	CbGbCtD
Flunitrazepam—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0187	0.0448	CbGbCtD
Flunitrazepam—UGT1A1—Etoposide—prostate cancer	0.0185	0.0445	CbGbCtD
Flunitrazepam—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0171	0.0409	CbGbCtD
Flunitrazepam—CYP2C9—Nilutamide—prostate cancer	0.0169	0.0405	CbGbCtD
Flunitrazepam—CYP2C9—Bicalutamide—prostate cancer	0.0169	0.0405	CbGbCtD
Flunitrazepam—CYP2C19—Flutamide—prostate cancer	0.0168	0.0404	CbGbCtD
Flunitrazepam—CYP1A2—Flutamide—prostate cancer	0.0155	0.0373	CbGbCtD
Flunitrazepam—CYP2E1—Mitoxantrone—prostate cancer	0.0115	0.0277	CbGbCtD
Flunitrazepam—CYP1A2—Estrone—prostate cancer	0.0112	0.0269	CbGbCtD
Flunitrazepam—CYP2C9—Estrone—prostate cancer	0.0101	0.0243	CbGbCtD
Flunitrazepam—CYP3A4—Bicalutamide—prostate cancer	0.00981	0.0236	CbGbCtD
Flunitrazepam—CYP3A4—Estramustine—prostate cancer	0.00912	0.0219	CbGbCtD
Flunitrazepam—CYP3A4—Abiraterone—prostate cancer	0.00813	0.0195	CbGbCtD
Flunitrazepam—CYP3A4—Flutamide—prostate cancer	0.00813	0.0195	CbGbCtD
Flunitrazepam—CYP2C9—Capecitabine—prostate cancer	0.00766	0.0184	CbGbCtD
Flunitrazepam—CYP1A2—Conjugated Estrogens—prostate cancer	0.00734	0.0176	CbGbCtD
Flunitrazepam—CYP2E1—Etoposide—prostate cancer	0.00727	0.0175	CbGbCtD
Flunitrazepam—CYP2C19—Estradiol—prostate cancer	0.00698	0.0168	CbGbCtD
Flunitrazepam—CYP1A2—Estradiol—prostate cancer	0.00644	0.0155	CbGbCtD
Flunitrazepam—CYP3A4—Cabazitaxel—prostate cancer	0.00601	0.0144	CbGbCtD
Flunitrazepam—CYP2C19—Prednisone—prostate cancer	0.006	0.0144	CbGbCtD
Flunitrazepam—CYP3A4—Estrone—prostate cancer	0.00588	0.0141	CbGbCtD
Flunitrazepam—CYP2C9—Estradiol—prostate cancer	0.00581	0.0139	CbGbCtD
Flunitrazepam—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00524	0.0126	CbGbCtD
Flunitrazepam—CYP2B6—Doxorubicin—prostate cancer	0.00489	0.0117	CbGbCtD
Flunitrazepam—CYP1A2—Etoposide—prostate cancer	0.00421	0.0101	CbGbCtD
Flunitrazepam—CYP3A4—Conjugated Estrogens—prostate cancer	0.00384	0.00923	CbGbCtD
Flunitrazepam—UGT1A1—urine—prostate cancer	0.00367	0.129	CbGeAlD
Flunitrazepam—CYP3A4—Mitoxantrone—prostate cancer	0.0035	0.00839	CbGbCtD
Flunitrazepam—CYP3A4—Estradiol—prostate cancer	0.00338	0.0081	CbGbCtD
Flunitrazepam—CYP3A4—Prednisone—prostate cancer	0.0029	0.00697	CbGbCtD
Flunitrazepam—CYP3A4—Etoposide—prostate cancer	0.0022	0.00529	CbGbCtD
Flunitrazepam—CYP3A4—Docetaxel—prostate cancer	0.00202	0.00484	CbGbCtD
Flunitrazepam—CYP2C19—urine—prostate cancer	0.00199	0.0698	CbGeAlD
Flunitrazepam—CYP1A2—urine—prostate cancer	0.00163	0.057	CbGeAlD
Flunitrazepam—UGT2B7—prostate gland—prostate cancer	0.00155	0.0544	CbGeAlD
Flunitrazepam—CYP2C9—urine—prostate cancer	0.00154	0.0541	CbGeAlD
Flunitrazepam—CYP3A4—Doxorubicin—prostate cancer	0.0015	0.00361	CbGbCtD
Flunitrazepam—CYP2E1—urine—prostate cancer	0.00146	0.0513	CbGeAlD
Flunitrazepam—UGT1A1—prostate gland—prostate cancer	0.00132	0.0462	CbGeAlD
Flunitrazepam—CYP3A4—urine—prostate cancer	0.00118	0.0413	CbGeAlD
Flunitrazepam—CYP2A6—prostate gland—prostate cancer	0.00111	0.039	CbGeAlD
Flunitrazepam—UGT2B7—renal system—prostate cancer	0.00106	0.0371	CbGeAlD
Flunitrazepam—CYP2A6—seminal vesicle—prostate cancer	0.00094	0.033	CbGeAlD
Flunitrazepam—TSPO—prostate gland—prostate cancer	0.000909	0.0319	CbGeAlD
Flunitrazepam—UGT1A1—renal system—prostate cancer	0.000899	0.0315	CbGeAlD
Flunitrazepam—TSPO—seminal vesicle—prostate cancer	0.000769	0.027	CbGeAlD
Flunitrazepam—UGT2B7—testis—prostate cancer	0.000683	0.024	CbGeAlD
Flunitrazepam—TSPO—epithelium—prostate cancer	0.000668	0.0234	CbGeAlD
Flunitrazepam—GABRA5—testis—prostate cancer	0.000624	0.0219	CbGeAlD
Flunitrazepam—TSPO—renal system—prostate cancer	0.00062	0.0217	CbGeAlD
Flunitrazepam—TSPO—urethra—prostate cancer	0.000609	0.0213	CbGeAlD
Flunitrazepam—GABRA3—testis—prostate cancer	0.000581	0.0204	CbGeAlD
Flunitrazepam—CYP2E1—prostate gland—prostate cancer	0.000525	0.0184	CbGeAlD
Flunitrazepam—TSPO—bone marrow—prostate cancer	0.000468	0.0164	CbGeAlD
Flunitrazepam—CYP2E1—seminal vesicle—prostate cancer	0.000444	0.0156	CbGeAlD
Flunitrazepam—TSPO—testis—prostate cancer	0.0004	0.014	CbGeAlD
Flunitrazepam—CYP1A2—renal system—prostate cancer	0.000398	0.014	CbGeAlD
Flunitrazepam—CYP2B6—renal system—prostate cancer	0.000381	0.0134	CbGeAlD
Flunitrazepam—CYP2E1—renal system—prostate cancer	0.000358	0.0126	CbGeAlD
Flunitrazepam—CYP2E1—urethra—prostate cancer	0.000352	0.0123	CbGeAlD
Flunitrazepam—Feeling abnormal—Degarelix—prostate cancer	0.00032	0.00464	CcSEcCtD
Flunitrazepam—Dysarthria—Capecitabine—prostate cancer	0.00032	0.00464	CcSEcCtD
Flunitrazepam—Confusional state—Bicalutamide—prostate cancer	0.000317	0.00459	CcSEcCtD
Flunitrazepam—Fatigue—Cabazitaxel—prostate cancer	0.000316	0.00458	CcSEcCtD
Flunitrazepam—GABRA2—lymph node—prostate cancer	0.000314	0.011	CbGeAlD
Flunitrazepam—Asthenia—Nilutamide—prostate cancer	0.000312	0.00453	CcSEcCtD
Flunitrazepam—Asthenia—Flutamide—prostate cancer	0.000311	0.0045	CcSEcCtD
Flunitrazepam—Dizziness—Estrone—prostate cancer	0.00031	0.00449	CcSEcCtD
Flunitrazepam—Rash—Estramustine—prostate cancer	0.000309	0.00448	CcSEcCtD
Flunitrazepam—Dermatitis—Estramustine—prostate cancer	0.000309	0.00448	CcSEcCtD
Flunitrazepam—Headache—Estramustine—prostate cancer	0.000307	0.00445	CcSEcCtD
Flunitrazepam—Clonazepam—NAT2—prostate cancer	0.000306	0.105	CrCbGaD
Flunitrazepam—Hyperhidrosis—Bicalutamide—prostate cancer	0.000304	0.0044	CcSEcCtD
Flunitrazepam—Hiccups—Capecitabine—prostate cancer	0.000303	0.00439	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Ethinyl Estradiol—prostate cancer	0.000302	0.00438	CcSEcCtD
Flunitrazepam—Feeling abnormal—Cabazitaxel—prostate cancer	0.000302	0.00437	CcSEcCtD
Flunitrazepam—Rash—Abiraterone—prostate cancer	0.0003	0.00435	CcSEcCtD
Flunitrazepam—Dermatitis—Abiraterone—prostate cancer	0.0003	0.00435	CcSEcCtD
Flunitrazepam—Angioedema—Ethinyl Estradiol—prostate cancer	0.000297	0.00431	CcSEcCtD
Flunitrazepam—Rash—Estrone—prostate cancer	0.000295	0.00428	CcSEcCtD
Flunitrazepam—Dermatitis—Estrone—prostate cancer	0.000295	0.00428	CcSEcCtD
Flunitrazepam—Headache—Estrone—prostate cancer	0.000293	0.00425	CcSEcCtD
Flunitrazepam—Malaise—Ethinyl Estradiol—prostate cancer	0.000293	0.00425	CcSEcCtD
Flunitrazepam—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.000293	0.00425	CcSEcCtD
Flunitrazepam—TSPO—lymph node—prostate cancer	0.00029	0.0102	CbGeAlD
Flunitrazepam—CYP3A4—renal system—prostate cancer	0.000288	0.0101	CbGeAlD
Flunitrazepam—Dizziness—Nilutamide—prostate cancer	0.000288	0.00417	CcSEcCtD
Flunitrazepam—Dizziness—Flutamide—prostate cancer	0.000286	0.00415	CcSEcCtD
Flunitrazepam—Somnolence—Bicalutamide—prostate cancer	0.000279	0.00405	CcSEcCtD
Flunitrazepam—Asthenia—Degarelix—prostate cancer	0.000279	0.00404	CcSEcCtD
Flunitrazepam—Anxiety—Ethinyl Estradiol—prostate cancer	0.000276	0.004	CcSEcCtD
Flunitrazepam—Rash—Nilutamide—prostate cancer	0.000274	0.00398	CcSEcCtD
Flunitrazepam—Dermatitis—Nilutamide—prostate cancer	0.000274	0.00397	CcSEcCtD
Flunitrazepam—Discomfort—Ethinyl Estradiol—prostate cancer	0.000274	0.00397	CcSEcCtD
Flunitrazepam—Rash—Flutamide—prostate cancer	0.000273	0.00396	CcSEcCtD
Flunitrazepam—Dermatitis—Flutamide—prostate cancer	0.000273	0.00396	CcSEcCtD
Flunitrazepam—Headache—Nilutamide—prostate cancer	0.000272	0.00395	CcSEcCtD
Flunitrazepam—Headache—Flutamide—prostate cancer	0.000271	0.00393	CcSEcCtD
Flunitrazepam—Fatigue—Bicalutamide—prostate cancer	0.000271	0.00393	CcSEcCtD
Flunitrazepam—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00027	0.00392	CcSEcCtD
Flunitrazepam—Hiccups—Prednisone—prostate cancer	0.00027	0.00391	CcSEcCtD
Flunitrazepam—Asthenia—Cabazitaxel—prostate cancer	0.000263	0.00381	CcSEcCtD
Flunitrazepam—Feeling abnormal—Bicalutamide—prostate cancer	0.000259	0.00375	CcSEcCtD
Flunitrazepam—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000258	0.00374	CcSEcCtD
Flunitrazepam—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000257	0.00373	CcSEcCtD
Flunitrazepam—Dizziness—Degarelix—prostate cancer	0.000257	0.00373	CcSEcCtD
Flunitrazepam—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000256	0.00371	CcSEcCtD
Flunitrazepam—Sleep disorder—Capecitabine—prostate cancer	0.000254	0.00368	CcSEcCtD
Flunitrazepam—Drowsiness—Mitoxantrone—prostate cancer	0.000253	0.00367	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Goserelin—prostate cancer	0.000248	0.0036	CcSEcCtD
Flunitrazepam—CYP2B6—testis—prostate cancer	0.000246	0.00865	CbGeAlD
Flunitrazepam—Rash—Degarelix—prostate cancer	0.000245	0.00355	CcSEcCtD
Flunitrazepam—Dermatitis—Degarelix—prostate cancer	0.000245	0.00355	CcSEcCtD
Flunitrazepam—Headache—Degarelix—prostate cancer	0.000243	0.00353	CcSEcCtD
Flunitrazepam—Sweating—Mitoxantrone—prostate cancer	0.000243	0.00352	CcSEcCtD
Flunitrazepam—Angioedema—Conjugated Estrogens—prostate cancer	0.000242	0.00351	CcSEcCtD
Flunitrazepam—Dizziness—Cabazitaxel—prostate cancer	0.000242	0.00351	CcSEcCtD
Flunitrazepam—Malaise—Goserelin—prostate cancer	0.000241	0.0035	CcSEcCtD
Flunitrazepam—Amnesia—Capecitabine—prostate cancer	0.000234	0.00339	CcSEcCtD
Flunitrazepam—CYP2E1—testis—prostate cancer	0.000231	0.00811	CbGeAlD
Flunitrazepam—Headache—Cabazitaxel—prostate cancer	0.000229	0.00332	CcSEcCtD
Flunitrazepam—Fatigue—Ethinyl Estradiol—prostate cancer	0.000229	0.00332	CcSEcCtD
Flunitrazepam—Anxiety—Goserelin—prostate cancer	0.000227	0.00329	CcSEcCtD
Flunitrazepam—Asthenia—Bicalutamide—prostate cancer	0.000225	0.00327	CcSEcCtD
Flunitrazepam—Discomfort—Goserelin—prostate cancer	0.000225	0.00326	CcSEcCtD
Flunitrazepam—Anxiety—Conjugated Estrogens—prostate cancer	0.000225	0.00326	CcSEcCtD
Flunitrazepam—Dysarthria—Epirubicin—prostate cancer	0.000223	0.00323	CcSEcCtD
Flunitrazepam—Dry mouth—Goserelin—prostate cancer	0.000223	0.00323	CcSEcCtD
Flunitrazepam—Confusional state—Goserelin—prostate cancer	0.00022	0.00319	CcSEcCtD
Flunitrazepam—Diplopia—Capecitabine—prostate cancer	0.00022	0.00319	CcSEcCtD
Flunitrazepam—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000219	0.00317	CcSEcCtD
Flunitrazepam—Ataxia—Docetaxel—prostate cancer	0.000213	0.00309	CcSEcCtD
Flunitrazepam—Tachycardia—Goserelin—prostate cancer	0.000213	0.00309	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Goserelin—prostate cancer	0.000211	0.00306	CcSEcCtD
Flunitrazepam—Tachycardia—Conjugated Estrogens—prostate cancer	0.000211	0.00306	CcSEcCtD
Flunitrazepam—Hiccups—Epirubicin—prostate cancer	0.000211	0.00306	CcSEcCtD
Flunitrazepam—Irritability—Capecitabine—prostate cancer	0.00021	0.00304	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Conjugated Estrogens—prostate cancer	0.000209	0.00303	CcSEcCtD
Flunitrazepam—Amnesia—Prednisone—prostate cancer	0.000208	0.00302	CcSEcCtD
Flunitrazepam—Dizziness—Bicalutamide—prostate cancer	0.000208	0.00301	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Docetaxel—prostate cancer	0.000207	0.00301	CcSEcCtD
Flunitrazepam—Ataxia—Capecitabine—prostate cancer	0.000207	0.003	CcSEcCtD
Flunitrazepam—Dysarthria—Doxorubicin—prostate cancer	0.000206	0.00299	CcSEcCtD
Flunitrazepam—Hypotension—Goserelin—prostate cancer	0.000204	0.00296	CcSEcCtD
Flunitrazepam—Hypotension—Conjugated Estrogens—prostate cancer	0.000202	0.00293	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Capecitabine—prostate cancer	0.000201	0.00291	CcSEcCtD
Flunitrazepam—Tremor—Estradiol—prostate cancer	0.000199	0.00288	CcSEcCtD
Flunitrazepam—Rash—Bicalutamide—prostate cancer	0.000198	0.00287	CcSEcCtD
Flunitrazepam—Dermatitis—Bicalutamide—prostate cancer	0.000198	0.00287	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Estradiol—prostate cancer	0.000197	0.00285	CcSEcCtD
Flunitrazepam—Headache—Bicalutamide—prostate cancer	0.000197	0.00285	CcSEcCtD
Flunitrazepam—Hiccups—Doxorubicin—prostate cancer	0.000195	0.00283	CcSEcCtD
Flunitrazepam—Agitation—Estradiol—prostate cancer	0.000195	0.00283	CcSEcCtD
Flunitrazepam—Somnolence—Goserelin—prostate cancer	0.000194	0.00282	CcSEcCtD
Flunitrazepam—Angioedema—Estradiol—prostate cancer	0.000194	0.00281	CcSEcCtD
Flunitrazepam—Muscular weakness—Capecitabine—prostate cancer	0.000194	0.00281	CcSEcCtD
Flunitrazepam—Somnolence—Conjugated Estrogens—prostate cancer	0.000192	0.00279	CcSEcCtD
Flunitrazepam—Malaise—Estradiol—prostate cancer	0.000191	0.00277	CcSEcCtD
Flunitrazepam—Psychotic disorder—Prednisone—prostate cancer	0.000191	0.00277	CcSEcCtD
Flunitrazepam—Asthenia—Ethinyl Estradiol—prostate cancer	0.00019	0.00276	CcSEcCtD
Flunitrazepam—Fatigue—Goserelin—prostate cancer	0.000188	0.00273	CcSEcCtD
Flunitrazepam—Irritability—Prednisone—prostate cancer	0.000187	0.00271	CcSEcCtD
Flunitrazepam—Fatigue—Conjugated Estrogens—prostate cancer	0.000187	0.0027	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Mitoxantrone—prostate cancer	0.000183	0.00266	CcSEcCtD
Flunitrazepam—Acenocoumarol—CYP2C19—prostate cancer	0.000181	0.0621	CrCbGaD
Flunitrazepam—Clotiazepam—CYP2C18—prostate cancer	0.000181	0.0621	CrCbGaD
Flunitrazepam—Anxiety—Estradiol—prostate cancer	0.00018	0.00261	CcSEcCtD
Flunitrazepam—Feeling abnormal—Goserelin—prostate cancer	0.00018	0.00261	CcSEcCtD
Flunitrazepam—Discomfort—Estradiol—prostate cancer	0.000178	0.00259	CcSEcCtD
Flunitrazepam—Malaise—Mitoxantrone—prostate cancer	0.000178	0.00259	CcSEcCtD
Flunitrazepam—Dry mouth—Estradiol—prostate cancer	0.000177	0.00256	CcSEcCtD
Flunitrazepam—Dizziness—Ethinyl Estradiol—prostate cancer	0.000176	0.00254	CcSEcCtD
Flunitrazepam—Confusional state—Estradiol—prostate cancer	0.000175	0.00253	CcSEcCtD
Flunitrazepam—Muscular weakness—Prednisone—prostate cancer	0.000173	0.0025	CcSEcCtD
Flunitrazepam—Clobazam—CYP2C18—prostate cancer	0.000171	0.0586	CrCbGaD
Flunitrazepam—Tachycardia—Estradiol—prostate cancer	0.000169	0.00245	CcSEcCtD
Flunitrazepam—Anxiety—Mitoxantrone—prostate cancer	0.000168	0.00243	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Estradiol—prostate cancer	0.000167	0.00243	CcSEcCtD
Flunitrazepam—Rash—Ethinyl Estradiol—prostate cancer	0.000167	0.00243	CcSEcCtD
Flunitrazepam—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000167	0.00242	CcSEcCtD
Flunitrazepam—Discomfort—Mitoxantrone—prostate cancer	0.000166	0.00241	CcSEcCtD
Flunitrazepam—Headache—Ethinyl Estradiol—prostate cancer	0.000166	0.00241	CcSEcCtD
Flunitrazepam—Confusional state—Mitoxantrone—prostate cancer	0.000163	0.00236	CcSEcCtD
Flunitrazepam—Tachycardia—Mitoxantrone—prostate cancer	0.000157	0.00228	CcSEcCtD
Flunitrazepam—Asthenia—Goserelin—prostate cancer	0.000157	0.00227	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000156	0.00226	CcSEcCtD
Flunitrazepam—Asthenia—Conjugated Estrogens—prostate cancer	0.000155	0.00225	CcSEcCtD
Flunitrazepam—Somnolence—Estradiol—prostate cancer	0.000154	0.00223	CcSEcCtD
Flunitrazepam—Diplopia—Epirubicin—prostate cancer	0.000153	0.00222	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Etoposide—prostate cancer	0.000153	0.00221	CcSEcCtD
Flunitrazepam—Hypotension—Mitoxantrone—prostate cancer	0.000151	0.00219	CcSEcCtD
Flunitrazepam—Fatigue—Estradiol—prostate cancer	0.000149	0.00216	CcSEcCtD
Flunitrazepam—Malaise—Etoposide—prostate cancer	0.000148	0.00215	CcSEcCtD
Flunitrazepam—Dizziness—Goserelin—prostate cancer	0.000144	0.00209	CcSEcCtD
Flunitrazepam—Ataxia—Epirubicin—prostate cancer	0.000144	0.00209	CcSEcCtD
Flunitrazepam—Somnolence—Mitoxantrone—prostate cancer	0.000143	0.00208	CcSEcCtD
Flunitrazepam—Dizziness—Conjugated Estrogens—prostate cancer	0.000143	0.00207	CcSEcCtD
Flunitrazepam—Feeling abnormal—Estradiol—prostate cancer	0.000143	0.00207	CcSEcCtD
Flunitrazepam—Diplopia—Doxorubicin—prostate cancer	0.000142	0.00205	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Epirubicin—prostate cancer	0.00014	0.00203	CcSEcCtD
Flunitrazepam—Fatigue—Mitoxantrone—prostate cancer	0.000139	0.00202	CcSEcCtD
Flunitrazepam—Discomfort—Etoposide—prostate cancer	0.000138	0.00201	CcSEcCtD
Flunitrazepam—Rash—Goserelin—prostate cancer	0.000138	0.002	CcSEcCtD
Flunitrazepam—Dermatitis—Goserelin—prostate cancer	0.000138	0.002	CcSEcCtD
Flunitrazepam—Headache—Goserelin—prostate cancer	0.000137	0.00198	CcSEcCtD
Flunitrazepam—Rash—Conjugated Estrogens—prostate cancer	0.000136	0.00198	CcSEcCtD
Flunitrazepam—Dermatitis—Conjugated Estrogens—prostate cancer	0.000136	0.00198	CcSEcCtD
Flunitrazepam—Headache—Conjugated Estrogens—prostate cancer	0.000136	0.00197	CcSEcCtD
Flunitrazepam—Confusional state—Etoposide—prostate cancer	0.000135	0.00196	CcSEcCtD
Flunitrazepam—Muscular weakness—Epirubicin—prostate cancer	0.000135	0.00196	CcSEcCtD
Flunitrazepam—Hallucination—Prednisone—prostate cancer	0.000135	0.00195	CcSEcCtD
Flunitrazepam—Ataxia—Doxorubicin—prostate cancer	0.000133	0.00193	CcSEcCtD
Flunitrazepam—Feeling abnormal—Mitoxantrone—prostate cancer	0.000133	0.00193	CcSEcCtD
Flunitrazepam—Tachycardia—Etoposide—prostate cancer	0.000131	0.0019	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Etoposide—prostate cancer	0.00013	0.00188	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Doxorubicin—prostate cancer	0.000129	0.00188	CcSEcCtD
Flunitrazepam—Hypotension—Etoposide—prostate cancer	0.000125	0.00182	CcSEcCtD
Flunitrazepam—Muscular weakness—Doxorubicin—prostate cancer	0.000125	0.00181	CcSEcCtD
Flunitrazepam—Asthenia—Estradiol—prostate cancer	0.000124	0.0018	CcSEcCtD
Flunitrazepam—Tremor—Capecitabine—prostate cancer	0.000124	0.0018	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Capecitabine—prostate cancer	0.000123	0.00178	CcSEcCtD
Flunitrazepam—Malaise—Capecitabine—prostate cancer	0.000119	0.00173	CcSEcCtD
Flunitrazepam—Somnolence—Etoposide—prostate cancer	0.000119	0.00173	CcSEcCtD
Flunitrazepam—Drowsiness—Epirubicin—prostate cancer	0.000118	0.00171	CcSEcCtD
Flunitrazepam—Asthenia—Mitoxantrone—prostate cancer	0.000116	0.00168	CcSEcCtD
Flunitrazepam—Fatigue—Etoposide—prostate cancer	0.000116	0.00168	CcSEcCtD
Flunitrazepam—Acenocoumarol—CYP3A4—prostate cancer	0.000115	0.0395	CrCbGaD
Flunitrazepam—Dizziness—Estradiol—prostate cancer	0.000115	0.00166	CcSEcCtD
Flunitrazepam—Dry mouth—Docetaxel—prostate cancer	0.000114	0.00165	CcSEcCtD
Flunitrazepam—Sweating—Epirubicin—prostate cancer	0.000113	0.00164	CcSEcCtD
Flunitrazepam—Confusional state—Docetaxel—prostate cancer	0.000112	0.00163	CcSEcCtD
Flunitrazepam—Alprazolam—CYP3A5—prostate cancer	0.000112	0.0386	CrCbGaD
Flunitrazepam—Anxiety—Capecitabine—prostate cancer	0.000112	0.00163	CcSEcCtD
Flunitrazepam—Discomfort—Capecitabine—prostate cancer	0.000111	0.00161	CcSEcCtD
Flunitrazepam—Feeling abnormal—Etoposide—prostate cancer	0.000111	0.0016	CcSEcCtD
Flunitrazepam—Dry mouth—Capecitabine—prostate cancer	0.00011	0.0016	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Prednisone—prostate cancer	0.000109	0.00159	CcSEcCtD
Flunitrazepam—Rash—Estradiol—prostate cancer	0.000109	0.00158	CcSEcCtD
Flunitrazepam—Drowsiness—Doxorubicin—prostate cancer	0.000109	0.00158	CcSEcCtD
Flunitrazepam—Dermatitis—Estradiol—prostate cancer	0.000109	0.00158	CcSEcCtD
Flunitrazepam—Confusional state—Capecitabine—prostate cancer	0.000109	0.00158	CcSEcCtD
Flunitrazepam—Tachycardia—Docetaxel—prostate cancer	0.000109	0.00158	CcSEcCtD
Flunitrazepam—Headache—Estradiol—prostate cancer	0.000108	0.00157	CcSEcCtD
Flunitrazepam—Agitation—Prednisone—prostate cancer	0.000108	0.00157	CcSEcCtD
Flunitrazepam—Angioedema—Prednisone—prostate cancer	0.000108	0.00156	CcSEcCtD
Flunitrazepam—Malaise—Prednisone—prostate cancer	0.000106	0.00154	CcSEcCtD
Flunitrazepam—Tachycardia—Capecitabine—prostate cancer	0.000105	0.00153	CcSEcCtD
Flunitrazepam—Sweating—Doxorubicin—prostate cancer	0.000105	0.00152	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Capecitabine—prostate cancer	0.000104	0.00151	CcSEcCtD
Flunitrazepam—Hypotension—Docetaxel—prostate cancer	0.000104	0.00151	CcSEcCtD
Flunitrazepam—Rash—Mitoxantrone—prostate cancer	0.000102	0.00148	CcSEcCtD
Flunitrazepam—Dermatitis—Mitoxantrone—prostate cancer	0.000102	0.00147	CcSEcCtD
Flunitrazepam—Headache—Mitoxantrone—prostate cancer	0.000101	0.00147	CcSEcCtD
Flunitrazepam—Hypotension—Capecitabine—prostate cancer	0.000101	0.00146	CcSEcCtD
Flunitrazepam—Anxiety—Prednisone—prostate cancer	0.0001	0.00145	CcSEcCtD
Flunitrazepam—Diazepam—CYP2C18—prostate cancer	9.96e-05	0.0342	CrCbGaD
Flunitrazepam—Somnolence—Docetaxel—prostate cancer	9.91e-05	0.00144	CcSEcCtD
Flunitrazepam—Discomfort—Prednisone—prostate cancer	9.91e-05	0.00144	CcSEcCtD
Flunitrazepam—Asthenia—Etoposide—prostate cancer	9.63e-05	0.0014	CcSEcCtD
Flunitrazepam—Fatigue—Docetaxel—prostate cancer	9.62e-05	0.00139	CcSEcCtD
Flunitrazepam—Midazolam—SLC22A1—prostate cancer	9.49e-05	0.0326	CrCbGaD
Flunitrazepam—Tachycardia—Prednisone—prostate cancer	9.39e-05	0.00136	CcSEcCtD
Flunitrazepam—Fatigue—Capecitabine—prostate cancer	9.31e-05	0.00135	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Prednisone—prostate cancer	9.3e-05	0.00135	CcSEcCtD
Flunitrazepam—Feeling abnormal—Docetaxel—prostate cancer	9.19e-05	0.00133	CcSEcCtD
Flunitrazepam—Feeling abnormal—Capecitabine—prostate cancer	8.9e-05	0.00129	CcSEcCtD
Flunitrazepam—Dizziness—Etoposide—prostate cancer	8.87e-05	0.00129	CcSEcCtD
Flunitrazepam—Clonazepam—CYP2E1—prostate cancer	8.81e-05	0.0303	CrCbGaD
Flunitrazepam—Ill-defined disorder—Epirubicin—prostate cancer	8.55e-05	0.00124	CcSEcCtD
Flunitrazepam—Agitation—Epirubicin—prostate cancer	8.47e-05	0.00123	CcSEcCtD
Flunitrazepam—Rash—Etoposide—prostate cancer	8.46e-05	0.00123	CcSEcCtD
Flunitrazepam—Dermatitis—Etoposide—prostate cancer	8.45e-05	0.00123	CcSEcCtD
Flunitrazepam—Headache—Etoposide—prostate cancer	8.41e-05	0.00122	CcSEcCtD
Flunitrazepam—Malaise—Epirubicin—prostate cancer	8.31e-05	0.00121	CcSEcCtD
Flunitrazepam—Fatigue—Prednisone—prostate cancer	8.29e-05	0.0012	CcSEcCtD
Flunitrazepam—Triazolam—CYP3A5—prostate cancer	8.25e-05	0.0283	CrCbGaD
Flunitrazepam—Clotiazepam—CYP2C19—prostate cancer	8.1e-05	0.0278	CrCbGaD
Flunitrazepam—Asthenia—Docetaxel—prostate cancer	8e-05	0.00116	CcSEcCtD
Flunitrazepam—Flurazepam—CYP2A6—prostate cancer	8e-05	0.0275	CrCbGaD
Flunitrazepam—Feeling abnormal—Prednisone—prostate cancer	7.93e-05	0.00115	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Doxorubicin—prostate cancer	7.91e-05	0.00115	CcSEcCtD
Flunitrazepam—Agitation—Doxorubicin—prostate cancer	7.84e-05	0.00114	CcSEcCtD
Flunitrazepam—Anxiety—Epirubicin—prostate cancer	7.82e-05	0.00113	CcSEcCtD
Flunitrazepam—Discomfort—Epirubicin—prostate cancer	7.75e-05	0.00112	CcSEcCtD
Flunitrazepam—Asthenia—Capecitabine—prostate cancer	7.75e-05	0.00112	CcSEcCtD
Flunitrazepam—Malaise—Doxorubicin—prostate cancer	7.69e-05	0.00112	CcSEcCtD
Flunitrazepam—Dry mouth—Epirubicin—prostate cancer	7.67e-05	0.00111	CcSEcCtD
Flunitrazepam—Midazolam—CYP3A5—prostate cancer	7.66e-05	0.0263	CrCbGaD
Flunitrazepam—Clobazam—CYP2C19—prostate cancer	7.65e-05	0.0263	CrCbGaD
Flunitrazepam—Confusional state—Epirubicin—prostate cancer	7.59e-05	0.0011	CcSEcCtD
Flunitrazepam—Quazepam—CYP2C19—prostate cancer	7.42e-05	0.0255	CrCbGaD
Flunitrazepam—Dizziness—Docetaxel—prostate cancer	7.38e-05	0.00107	CcSEcCtD
Flunitrazepam—Tachycardia—Epirubicin—prostate cancer	7.34e-05	0.00106	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Epirubicin—prostate cancer	7.27e-05	0.00105	CcSEcCtD
Flunitrazepam—Anxiety—Doxorubicin—prostate cancer	7.24e-05	0.00105	CcSEcCtD
Flunitrazepam—Discomfort—Doxorubicin—prostate cancer	7.17e-05	0.00104	CcSEcCtD
Flunitrazepam—Dizziness—Capecitabine—prostate cancer	7.14e-05	0.00104	CcSEcCtD
Flunitrazepam—Dry mouth—Doxorubicin—prostate cancer	7.1e-05	0.00103	CcSEcCtD
Flunitrazepam—Rash—Docetaxel—prostate cancer	7.03e-05	0.00102	CcSEcCtD
Flunitrazepam—Hypotension—Epirubicin—prostate cancer	7.03e-05	0.00102	CcSEcCtD
Flunitrazepam—Dermatitis—Docetaxel—prostate cancer	7.03e-05	0.00102	CcSEcCtD
Flunitrazepam—Confusional state—Doxorubicin—prostate cancer	7.02e-05	0.00102	CcSEcCtD
Flunitrazepam—Headache—Docetaxel—prostate cancer	6.99e-05	0.00101	CcSEcCtD
Flunitrazepam—Asthenia—Prednisone—prostate cancer	6.9e-05	0.001	CcSEcCtD
Flunitrazepam—Ketazolam—CYP3A4—prostate cancer	6.88e-05	0.0236	CrCbGaD
Flunitrazepam—Rash—Capecitabine—prostate cancer	6.81e-05	0.000987	CcSEcCtD
Flunitrazepam—Dermatitis—Capecitabine—prostate cancer	6.8e-05	0.000986	CcSEcCtD
Flunitrazepam—Tachycardia—Doxorubicin—prostate cancer	6.79e-05	0.000985	CcSEcCtD
Flunitrazepam—Headache—Capecitabine—prostate cancer	6.76e-05	0.000981	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Doxorubicin—prostate cancer	6.73e-05	0.000976	CcSEcCtD
Flunitrazepam—Somnolence—Epirubicin—prostate cancer	6.69e-05	0.00097	CcSEcCtD
Flunitrazepam—Diazepam—CYP3A5—prostate cancer	6.56e-05	0.0225	CrCbGaD
Flunitrazepam—Hypotension—Doxorubicin—prostate cancer	6.5e-05	0.000943	CcSEcCtD
Flunitrazepam—Fatigue—Epirubicin—prostate cancer	6.49e-05	0.00094	CcSEcCtD
Flunitrazepam—Nitrazepam—CYP2E1—prostate cancer	6.39e-05	0.0219	CrCbGaD
Flunitrazepam—Dizziness—Prednisone—prostate cancer	6.36e-05	0.000922	CcSEcCtD
Flunitrazepam—Adinazolam—CYP2C19—prostate cancer	6.24e-05	0.0214	CrCbGaD
Flunitrazepam—Feeling abnormal—Epirubicin—prostate cancer	6.2e-05	0.000899	CcSEcCtD
Flunitrazepam—Somnolence—Doxorubicin—prostate cancer	6.19e-05	0.000897	CcSEcCtD
Flunitrazepam—Rash—Prednisone—prostate cancer	6.06e-05	0.000879	CcSEcCtD
Flunitrazepam—Dermatitis—Prednisone—prostate cancer	6.06e-05	0.000879	CcSEcCtD
Flunitrazepam—Headache—Prednisone—prostate cancer	6.03e-05	0.000874	CcSEcCtD
Flunitrazepam—Fatigue—Doxorubicin—prostate cancer	6e-05	0.00087	CcSEcCtD
Flunitrazepam—Feeling abnormal—Doxorubicin—prostate cancer	5.74e-05	0.000832	CcSEcCtD
Flunitrazepam—Flurazepam—CYP2E1—prostate cancer	5.68e-05	0.0195	CrCbGaD
Flunitrazepam—Clonazepam—CYP3A4—prostate cancer	5.55e-05	0.0191	CrCbGaD
Flunitrazepam—Asthenia—Epirubicin—prostate cancer	5.4e-05	0.000783	CcSEcCtD
Flunitrazepam—Temazepam—CYP2C19—prostate cancer	5.38e-05	0.0185	CrCbGaD
Flunitrazepam—Midazolam—CYP2E1—prostate cancer	5.26e-05	0.0181	CrCbGaD
Flunitrazepam—Clotiazepam—CYP3A4—prostate cancer	5.15e-05	0.0177	CrCbGaD
Flunitrazepam—Asthenia—Doxorubicin—prostate cancer	4.99e-05	0.000724	CcSEcCtD
Flunitrazepam—Dizziness—Epirubicin—prostate cancer	4.97e-05	0.000721	CcSEcCtD
Flunitrazepam—Clobazam—CYP3A4—prostate cancer	4.87e-05	0.0167	CrCbGaD
Flunitrazepam—Alprazolam—CYP3A4—prostate cancer	4.87e-05	0.0167	CrCbGaD
Flunitrazepam—Rash—Epirubicin—prostate cancer	4.74e-05	0.000688	CcSEcCtD
Flunitrazepam—Dermatitis—Epirubicin—prostate cancer	4.74e-05	0.000687	CcSEcCtD
Flunitrazepam—Quazepam—CYP3A4—prostate cancer	4.72e-05	0.0162	CrCbGaD
Flunitrazepam—Headache—Epirubicin—prostate cancer	4.71e-05	0.000683	CcSEcCtD
Flunitrazepam—Dizziness—Doxorubicin—prostate cancer	4.6e-05	0.000667	CcSEcCtD
Flunitrazepam—Diazepam—CYP2E1—prostate cancer	4.51e-05	0.0155	CrCbGaD
Flunitrazepam—Diazepam—CYP2C19—prostate cancer	4.47e-05	0.0153	CrCbGaD
Flunitrazepam—Rash—Doxorubicin—prostate cancer	4.39e-05	0.000636	CcSEcCtD
Flunitrazepam—Dermatitis—Doxorubicin—prostate cancer	4.38e-05	0.000636	CcSEcCtD
Flunitrazepam—Headache—Doxorubicin—prostate cancer	4.36e-05	0.000632	CcSEcCtD
Flunitrazepam—Estazolam—CYP3A4—prostate cancer	4.17e-05	0.0143	CrCbGaD
Flunitrazepam—Nitrazepam—CYP3A4—prostate cancer	4.02e-05	0.0138	CrCbGaD
Flunitrazepam—Adinazolam—CYP3A4—prostate cancer	3.97e-05	0.0136	CrCbGaD
Flunitrazepam—Prazepam—CYP3A4—prostate cancer	3.83e-05	0.0132	CrCbGaD
Flunitrazepam—Flurazepam—CYP3A4—prostate cancer	3.58e-05	0.0123	CrCbGaD
Flunitrazepam—Triazolam—CYP3A4—prostate cancer	3.57e-05	0.0123	CrCbGaD
Flunitrazepam—Temazepam—CYP3A4—prostate cancer	3.42e-05	0.0117	CrCbGaD
Flunitrazepam—Midazolam—CYP3A4—prostate cancer	3.31e-05	0.0114	CrCbGaD
Flunitrazepam—Diazepam—CYP3A4—prostate cancer	2.84e-05	0.00976	CrCbGaD
Flunitrazepam—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.29e-06	1.93e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.29e-06	1.93e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP17A1—prostate cancer	2.27e-06	1.92e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SLC5A5—prostate cancer	2.26e-06	1.91e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—TYMS—prostate cancer	2.24e-06	1.9e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CAV1—prostate cancer	2.24e-06	1.89e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.24e-06	1.89e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GSTM1—prostate cancer	2.22e-06	1.87e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NCOA3—prostate cancer	2.21e-06	1.87e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP2E1—prostate cancer	2.21e-06	1.87e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—NOS3—prostate cancer	2.2e-06	1.86e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—TYMS—prostate cancer	2.2e-06	1.86e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTA4—prostate cancer	2.19e-06	1.85e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.19e-06	1.85e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NQO1—prostate cancer	2.18e-06	1.85e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.17e-06	1.84e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—LPL—prostate cancer	2.17e-06	1.84e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GSTM1—prostate cancer	2.17e-06	1.83e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NCOA2—prostate cancer	2.16e-06	1.83e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PTEN—prostate cancer	2.16e-06	1.82e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—TH—prostate cancer	2.15e-06	1.82e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.14e-06	1.81e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTA2—prostate cancer	2.14e-06	1.81e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP3A4—prostate cancer	2.13e-06	1.8e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—LPL—prostate cancer	2.13e-06	1.8e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.12e-06	1.79e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—HPGDS—prostate cancer	2.11e-06	1.79e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ABCG5—prostate cancer	2.11e-06	1.78e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.11e-06	1.78e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP1A1—prostate cancer	2.1e-06	1.78e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP2C19—prostate cancer	2.1e-06	1.77e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.09e-06	1.77e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ERCC2—prostate cancer	2.08e-06	1.76e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.06e-06	1.74e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTA1—prostate cancer	2.06e-06	1.74e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP1A1—prostate cancer	2.06e-06	1.74e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—EP300—prostate cancer	2.06e-06	1.74e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ACHE—prostate cancer	2.05e-06	1.73e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTT1—prostate cancer	2.05e-06	1.73e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ERCC2—prostate cancer	2.04e-06	1.73e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CG—prostate cancer	2.04e-06	1.72e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.04e-06	1.72e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTO1—prostate cancer	2.04e-06	1.72e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NAT2—prostate cancer	2.04e-06	1.72e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GGT1—prostate cancer	2.03e-06	1.72e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CB—prostate cancer	2.03e-06	1.71e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.02e-06	1.71e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.02e-06	1.71e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.01e-06	1.7e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTGS2—prostate cancer	2.01e-06	1.7e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NCOA1—prostate cancer	2e-06	1.69e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NQO1—prostate cancer	1.99e-06	1.68e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKR1C3—prostate cancer	1.97e-06	1.67e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.97e-06	1.66e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—TH—prostate cancer	1.96e-06	1.66e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PRKACB—prostate cancer	1.96e-06	1.66e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—MTHFR—prostate cancer	1.96e-06	1.66e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PLCB2—prostate cancer	1.95e-06	1.65e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.95e-06	1.65e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—LRP2—prostate cancer	1.95e-06	1.65e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.95e-06	1.65e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.94e-06	1.64e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP17A1—prostate cancer	1.94e-06	1.64e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.93e-06	1.63e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—INS—prostate cancer	1.93e-06	1.63e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PPARA—prostate cancer	1.92e-06	1.62e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—MTHFR—prostate cancer	1.92e-06	1.62e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—P4HB—prostate cancer	1.92e-06	1.62e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.91e-06	1.62e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.91e-06	1.61e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—RXRA—prostate cancer	1.9e-06	1.61e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CREBBP—prostate cancer	1.89e-06	1.6e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PPARA—prostate cancer	1.88e-06	1.59e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.86e-06	1.58e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GGT1—prostate cancer	1.85e-06	1.56e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.85e-06	1.56e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NCOA2—prostate cancer	1.85e-06	1.56e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—COMT—prostate cancer	1.83e-06	1.55e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTP1—prostate cancer	1.82e-06	1.54e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NCOA1—prostate cancer	1.82e-06	1.54e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.82e-06	1.54e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CAV1—prostate cancer	1.81e-06	1.53e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.8e-06	1.52e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ITPR1—prostate cancer	1.79e-06	1.52e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CD—prostate cancer	1.79e-06	1.52e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—PIK3CA—prostate cancer	1.79e-06	1.51e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—MED12—prostate cancer	1.79e-06	1.51e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GNG5—prostate cancer	1.77e-06	1.5e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CAV1—prostate cancer	1.77e-06	1.5e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.76e-06	1.49e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.76e-06	1.49e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PTEN—prostate cancer	1.75e-06	1.48e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—RXRA—prostate cancer	1.73e-06	1.47e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.72e-06	1.46e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NCOA3—prostate cancer	1.71e-06	1.44e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NQO1—prostate cancer	1.7e-06	1.44e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—TYMS—prostate cancer	1.69e-06	1.43e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—NOS3—prostate cancer	1.69e-06	1.43e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.69e-06	1.43e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—TH—prostate cancer	1.68e-06	1.42e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GSTM1—prostate cancer	1.67e-06	1.42e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—EP300—prostate cancer	1.67e-06	1.41e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—COMT—prostate cancer	1.67e-06	1.41e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.67e-06	1.41e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTP1—prostate cancer	1.66e-06	1.4e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.66e-06	1.4e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.65e-06	1.4e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CG—prostate cancer	1.65e-06	1.39e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—LPL—prostate cancer	1.64e-06	1.39e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ITPR1—prostate cancer	1.63e-06	1.38e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.63e-06	1.38e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—HPGDS—prostate cancer	1.63e-06	1.38e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.62e-06	1.37e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.61e-06	1.36e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.61e-06	1.36e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.59e-06	1.34e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTT1—prostate cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ACHE—prostate cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GGT1—prostate cancer	1.58e-06	1.34e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ERCC2—prostate cancer	1.57e-06	1.33e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CB—prostate cancer	1.56e-06	1.32e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.56e-06	1.32e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—INS—prostate cancer	1.56e-06	1.32e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NCOA1—prostate cancer	1.56e-06	1.32e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTGS2—prostate cancer	1.55e-06	1.31e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—TYMS—prostate cancer	1.54e-06	1.31e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.53e-06	1.3e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GSTM1—prostate cancer	1.53e-06	1.29e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CREBBP—prostate cancer	1.53e-06	1.29e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—INS—prostate cancer	1.53e-06	1.29e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—PIK3CA—prostate cancer	1.52e-06	1.29e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.52e-06	1.29e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PRKACB—prostate cancer	1.51e-06	1.28e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—LPL—prostate cancer	1.5e-06	1.27e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.5e-06	1.27e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CREBBP—prostate cancer	1.49e-06	1.26e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—RXRA—prostate cancer	1.48e-06	1.25e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—MTHFR—prostate cancer	1.48e-06	1.25e-05	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—AKT1—prostate cancer	1.46e-06	1.24e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PPARA—prostate cancer	1.45e-06	1.23e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.45e-06	1.22e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CD—prostate cancer	1.45e-06	1.22e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.44e-06	1.22e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ERCC2—prostate cancer	1.44e-06	1.21e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—COMT—prostate cancer	1.43e-06	1.21e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NCOA2—prostate cancer	1.43e-06	1.21e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTP1—prostate cancer	1.42e-06	1.2e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.42e-06	1.2e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ITPR1—prostate cancer	1.4e-06	1.18e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.37e-06	1.16e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—NOS3—prostate cancer	1.37e-06	1.15e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CAV1—prostate cancer	1.36e-06	1.15e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.36e-06	1.15e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PTEN—prostate cancer	1.35e-06	1.14e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—MTHFR—prostate cancer	1.35e-06	1.14e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—NOS3—prostate cancer	1.34e-06	1.13e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.33e-06	1.12e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PPARA—prostate cancer	1.32e-06	1.12e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—TYMS—prostate cancer	1.32e-06	1.12e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NQO1—prostate cancer	1.31e-06	1.11e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GSTM1—prostate cancer	1.3e-06	1.1e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.3e-06	1.1e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—TH—prostate cancer	1.29e-06	1.09e-05	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—EP300—prostate cancer	1.29e-06	1.09e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—LPL—prostate cancer	1.28e-06	1.08e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.26e-06	1.07e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.26e-06	1.06e-05	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTGS2—prostate cancer	1.25e-06	1.06e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CAV1—prostate cancer	1.24e-06	1.05e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.24e-06	1.05e-05	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—AKT1—prostate cancer	1.24e-06	1.05e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.24e-06	1.05e-05	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—PIK3CA—prostate cancer	1.24e-06	1.04e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.23e-06	1.04e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ERCC2—prostate cancer	1.23e-06	1.04e-05	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTGS2—prostate cancer	1.22e-06	1.03e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GGT1—prostate cancer	1.22e-06	1.03e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NCOA1—prostate cancer	1.2e-06	1.02e-05	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.19e-06	1.01e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.18e-06	1e-05	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—INS—prostate cancer	1.18e-06	9.95e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—MTHFR—prostate cancer	1.15e-06	9.75e-06	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CREBBP—prostate cancer	1.15e-06	9.75e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—RXRA—prostate cancer	1.14e-06	9.66e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.13e-06	9.59e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PPARA—prostate cancer	1.13e-06	9.56e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—COMT—prostate cancer	1.1e-06	9.31e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTP1—prostate cancer	1.1e-06	9.26e-06	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.09e-06	9.24e-06	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PTEN—prostate cancer	1.09e-06	9.21e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ITPR1—prostate cancer	1.08e-06	9.12e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—INS—prostate cancer	1.07e-06	9.07e-06	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PTEN—prostate cancer	1.07e-06	9.02e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CAV1—prostate cancer	1.06e-06	8.99e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CREBBP—prostate cancer	1.05e-06	8.89e-06	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—EP300—prostate cancer	1.04e-06	8.78e-06	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—NOS3—prostate cancer	1.03e-06	8.73e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—TYMS—prostate cancer	1.02e-06	8.61e-06	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—EP300—prostate cancer	1.02e-06	8.6e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.02e-06	8.59e-06	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—AKT1—prostate cancer	1.01e-06	8.53e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GSTM1—prostate cancer	1.01e-06	8.51e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CD—prostate cancer	9.96e-07	8.43e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—LPL—prostate cancer	9.88e-07	8.36e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CG—prostate cancer	9.69e-07	8.19e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.54e-07	8.07e-06	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CB—prostate cancer	9.53e-07	8.05e-06	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—PIK3CA—prostate cancer	9.52e-07	8.05e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ERCC2—prostate cancer	9.47e-07	8e-06	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTGS2—prostate cancer	9.44e-07	7.98e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—NOS3—prostate cancer	9.41e-07	7.96e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—INS—prostate cancer	9.17e-07	7.75e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CREBBP—prostate cancer	8.98e-07	7.59e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—MTHFR—prostate cancer	8.9e-07	7.52e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PPARA—prostate cancer	8.73e-07	7.38e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CB—prostate cancer	8.69e-07	7.34e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTGS2—prostate cancer	8.61e-07	7.28e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CD—prostate cancer	8.51e-07	7.2e-06	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PTEN—prostate cancer	8.23e-07	6.96e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CAV1—prostate cancer	8.21e-07	6.94e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—NOS3—prostate cancer	8.04e-07	6.8e-06	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—EP300—prostate cancer	7.85e-07	6.64e-06	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—AKT1—prostate cancer	7.78e-07	6.58e-06	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—PIK3CA—prostate cancer	7.68e-07	6.5e-06	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—PIK3CA—prostate cancer	7.53e-07	6.36e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PTEN—prostate cancer	7.51e-07	6.35e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.48e-07	6.32e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CB—prostate cancer	7.42e-07	6.28e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTGS2—prostate cancer	7.35e-07	6.22e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—EP300—prostate cancer	7.16e-07	6.05e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—INS—prostate cancer	7.08e-07	5.98e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CREBBP—prostate cancer	6.93e-07	5.86e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.57e-07	5.56e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PTEN—prostate cancer	6.41e-07	5.42e-06	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—AKT1—prostate cancer	6.28e-07	5.31e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—NOS3—prostate cancer	6.21e-07	5.25e-06	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—AKT1—prostate cancer	6.15e-07	5.2e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—EP300—prostate cancer	6.12e-07	5.17e-06	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—PIK3CA—prostate cancer	5.81e-07	4.91e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.73e-07	4.84e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTGS2—prostate cancer	5.68e-07	4.8e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—PIK3CA—prostate cancer	5.29e-07	4.48e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PTEN—prostate cancer	4.95e-07	4.19e-06	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—AKT1—prostate cancer	4.74e-07	4.01e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—EP300—prostate cancer	4.72e-07	3.99e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—PIK3CA—prostate cancer	4.52e-07	3.83e-06	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—AKT1—prostate cancer	4.33e-07	3.66e-06	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—AKT1—prostate cancer	3.7e-07	3.13e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.49e-07	2.95e-06	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—AKT1—prostate cancer	2.85e-07	2.41e-06	CbGpPWpGaD
